8th Apr 2021 14:21
SkinBioTherapeutics PLC - Manchester-based life science company - Starts research programme with University of Manchester into products that may reduce inflammation in the skin. Programme expands collaboration with the university, using funds raised in October placing and open offer. Company will pursue commercialisation of any successful formulations.
Current stock price: 57.12 pence
Year-to-date change: up sharply from 23.50p at end of 2020
By Ivan Edwards; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Skinbiotherap.